1. Home
  2. BCC vs ARQT Comparison

BCC vs ARQT Comparison

Compare BCC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boise Cascade L.L.C.

BCC

Boise Cascade L.L.C.

HOLD

Current Price

$75.84

Market Cap

2.6B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$26.13

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCC
ARQT
Founded
2004
2016
Country
United States
United States
Employees
7680
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
BCC
ARQT
Price
$75.84
$26.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$99.20
$34.00
AVG Volume (30 Days)
406.5K
1.8M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
88.79
EPS
0.50
N/A
Revenue
$4,995,290,000.00
$376,072,000.00
Revenue This Year
$3.41
$34.85
Revenue Next Year
$4.76
$29.39
P/E Ratio
$155.26
N/A
Revenue Growth
12.71
91.34
52 Week Low
$65.00
$13.06
52 Week High
$95.00
$31.77

Technical Indicators

Market Signals
Indicator
BCC
ARQT
Relative Strength Index (RSI) 55.68 61.15
Support Level $71.49 $24.81
Resistance Level $78.96 $27.26
Average True Range (ATR) 2.89 1.21
MACD 0.74 0.05
Stochastic Oscillator 61.23 58.97

Price Performance

Historical Comparison
BCC
ARQT

About BCC Boise Cascade L.L.C.

Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: